According to Market IntelliX Research, the global market for Medication for Portal Hypertension should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Medication for Portal Hypertension market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Medication for Portal Hypertension market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Beta-Blockers segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospital has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.

The global key manufacturers of Medication for Portal Hypertension include Genextra S.p.a., Sun Pharmaceuticals Industries Ltd., Chiasma Inc, Ono Pharmaceutical Co., Ltd., Novartis AG, Dr. Falk Pharma GmbH, Gilead Sciences Inc., United Therapeutics Corporation and Debiovision, Inc., etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Medication for Portal Hypertension. Report Highlights:

(1) Global Medication for Portal Hypertension market size (sales volume & revenue),history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Medication for Portal Hypertension market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(3) China Medication for Portal Hypertension market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(4) Global Medication for Portal Hypertension segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Medication for Portal Hypertension segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Medication for Portal Hypertension, capacity, production and trends.

(7) Medication for Portal Hypertension industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Beta-Blockers

Vasodilators

Lactulose

Antibiotics

Diuretics

Market segment by application, can be divided into

Hospital

Specialist Clinic

Others

Market segment by players, this report covers

Genextra S.p.a.

Sun Pharmaceuticals Industries Ltd.

Chiasma Inc

Ono Pharmaceutical Co., Ltd.

Novartis AG

Dr. Falk Pharma GmbH

Gilead Sciences Inc.

United Therapeutics Corporation

Debiovision, Inc.

1 Market Overview

1.1 Medication for Portal Hypertension Definition

1.2 Global Medication for Portal Hypertension Market Size and Forecast

1.2.1 By Revenue, Global Medication for Portal Hypertension Market Size, 2019-2030

1.2.2 By Sales Volume, Global Medication for Portal Hypertension Market Size, 2019-2030

1.2.3 Global Medication for Portal Hypertension Price Trend, 2019-2030

1.3 China Medication for Portal Hypertension Market Size and Forecast

1.3.1 By Revenue, China Medication for Portal Hypertension Market Size, 2019-2030

1.3.2 By Sales Volume, China Medication for Portal Hypertension Market Size, 2019-2030

1.3.3 China Medication for Portal Hypertension Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Medication for Portal Hypertension Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China Medication for Portal Hypertension Share in Global Market, 2019-2030

1.4.3 Medication for Portal Hypertension Market Size: China VS Global, 2019-2030

1.5 Medication for Portal Hypertension Market Dynamics

1.5.1 Medication for Portal Hypertension Market Drivers

1.5.2 Medication for Portal Hypertension Market Restraints

1.5.3 Medication for Portal Hypertension Industry Trends

1.5.4 Medication for Portal Hypertension Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Medication for Portal Hypertension Revenue by Company, 2019-2024

2.2 Global Medication for Portal Hypertension Sales Volume by Company, 2019-2024

2.3 Global Medication for Portal Hypertension Price by Company, 2019-2024

2.4 Global Medication for Portal Hypertension Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Medication for Portal Hypertension Concentration Ratio

2.6 Global Medication for Portal Hypertension Mergers & Acquisitions, Expansion Plans

2.7 Global Medication for Portal Hypertension Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Medication for Portal Hypertension Revenue by Company, 2019-2024

3.2 China Medication for Portal Hypertension Sales Volume by Company, 2019-2024

3.3 China Medication for Portal Hypertension Medication for Portal Hypertension Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Medication for Portal Hypertension Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)

3.5 Chinese Local Players, Medication for Portal Hypertension Domestic VS Export

3.6 China Market, Medication for Portal Hypertension Import & Export

3.6.1 China Market, Medication for Portal Hypertension Import & Export, 2019-2030

3.6.2 China Medication for Portal Hypertension Import & Export Trends

3.6.3 Main Sources of China Medication for Portal Hypertension Import

3.6.4 Export Destination of China Medication for Portal Hypertension

4 Medication for Portal Hypertension Production by Region

4.1 Global Medication for Portal Hypertension Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of Medication for Portal Hypertension Manufacturers

4.3 Global Major Manufacturers, Medication for Portal Hypertension Capacity Expansion and Future Plans

4.4 Global Medication for Portal Hypertension Capacity by Region

4.5 Global Medication for Portal Hypertension Production by Region

4.5.1 Global Medication for Portal Hypertension Production & Forecast by Region, 2019 VS 2024 VS 2030

4.5.2 Global Medication for Portal Hypertension Production by Region, 2019-2024

4.5.3 Global Medication for Portal Hypertension Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Medication for Portal Hypertension Industry Chain

5.2 Medication for Portal Hypertension Upstream Analysis

5.2.1 Medication for Portal Hypertension Core Raw Materials

5.2.2 Main Manufacturers of Medication for Portal Hypertension Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Medication for Portal Hypertension Production Mode

5.6 Medication for Portal Hypertension Procurement Model

5.7 Medication for Portal Hypertension Industry Sales Model and Sales Channels

5.7.1 Medication for Portal Hypertension Sales Model

5.7.2 Medication for Portal Hypertension Typical Distributors

6 Sights by Type

6.1 Medication for Portal Hypertension Classification

6.1.1 Beta-Blockers

6.1.2 Vasodilators

6.1.3 Lactulose

6.1.4 Antibiotics

6.1.5 Diuretics

6.2 By Type, Global Medication for Portal Hypertension Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Type, Global Medication for Portal Hypertension Revenue, 2019-2030

6.4 By Type, Global Medication for Portal Hypertension Sales Volume, 2019-2030

6.5 By Type, Global Medication for Portal Hypertension Price, 2019-2030

7 Sights by Application

7.1 Medication for Portal Hypertension Segment by Application

7.1.1 Hospital

7.1.2 Specialist Clinic

7.1.3 Others

7.2 By Application, Global Medication for Portal Hypertension Market Size & CAGR, 2019 VS 2024 VS 2030

7.3 By Application, Global Medication for Portal Hypertension Revenue, 2019-2030

7.4 By Application, Global Medication for Portal Hypertension Sales Volume, 2019-2030

7.5 By Application, Global Medication for Portal Hypertension Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Medication for Portal Hypertension Market Size, 2019 VS 2024 VS 2030

8.2 By Region, Global Medication for Portal Hypertension Revenue, 2019-2030

8.3 By Region, Global Medication for Portal Hypertension Sales Volume, 2019-2030

8.4 North America

8.4.1 North America Medication for Portal Hypertension Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America Medication for Portal Hypertension Market Size Market Share

8.5 Europe

8.5.1 Europe Medication for Portal Hypertension Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Medication for Portal Hypertension Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Medication for Portal Hypertension Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Medication for Portal Hypertension Market Size Market Share

8.7 South America

8.7.1 South America Medication for Portal Hypertension Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Medication for Portal Hypertension Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Medication for Portal Hypertension Market Size & CAGR，2019 VS 2024 VS 2030

9.2 By Country, Global Medication for Portal Hypertension Revenue, 2019-2030

9.3 By Country, Global Medication for Portal Hypertension Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. Medication for Portal Hypertension Market Size, 2019-2030

9.4.2 By Company, U.S. Medication for Portal Hypertension Sales Volume Market Share, 2023

9.4.3 By Type, U.S. Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.4.4 By Application, U.S. Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.5 Europe

9.5.1 Europe Medication for Portal Hypertension Market Size, 2019-2030

9.5.2 By Company, Europe Medication for Portal Hypertension Sales Volume Market Share, 2023

9.5.3 By Type, Europe Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.5.4 By Application, Europe Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.6 China

9.6.1 China Medication for Portal Hypertension Market Size, 2019-2030

9.6.2 By Company, China Medication for Portal Hypertension Sales Volume Market Share, 2023

9.6.3 By Type, China Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.6.4 By Application, China Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.7 Japan

9.7.1 Japan Medication for Portal Hypertension Market Size, 2019-2030

9.7.2 By Company, Japan Medication for Portal Hypertension Sales Volume Market Share, 2023

9.7.3 By Type, Japan Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.7.4 By Application, Japan Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.8 South Korea

9.8.1 South Korea Medication for Portal Hypertension Market Size, 2019-2030

9.8.2 By Company, South Korea Medication for Portal Hypertension Sales Volume Market Share, 2023

9.8.3 By Type, South Korea Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.8.4 By Application, South Korea Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia Medication for Portal Hypertension Market Size, 2019-2030

9.9.2 By Company, Southeast Asia Medication for Portal Hypertension Sales Volume Market Share, 2023

9.9.3 By Type, Southeast Asia Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.9.4 By Application, Southeast Asia Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.10 India

9.10.1 India Medication for Portal Hypertension Market Size, 2019-2030

9.10.2 By Company, India Medication for Portal Hypertension Sales Volume Market Share, 2023

9.10.3 By Type, India Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.10.4 By Application, India Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia Medication for Portal Hypertension Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia Medication for Portal Hypertension Sales Volume Market Share, 2023

9.11.3 By Type, Middle East & Asia Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

9.11.4 By Application, Middle East & Asia Medication for Portal Hypertension Market Size, Share, 2023 VS 2030

10 Manufacturers Profile

10.1 Genextra S.p.a.

10.1.1 Genextra S.p.a. Company Information, Head Office, Market Area and Industry Position

10.1.2 Genextra S.p.a. Medication for Portal Hypertension Models, Specifications and Application

10.1.3 Genextra S.p.a. Medication for Portal Hypertension Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.1.4 Genextra S.p.a. Company Profile and Main Business

10.1.5 Genextra S.p.a. Recent Developments

10.2 Sun Pharmaceuticals Industries Ltd.

10.2.1 Sun Pharmaceuticals Industries Ltd. Company Information, Head Office, Market Area and Industry Position

10.2.2 Sun Pharmaceuticals Industries Ltd. Medication for Portal Hypertension Models, Specifications and Application

10.2.3 Sun Pharmaceuticals Industries Ltd. Medication for Portal Hypertension Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.2.4 Sun Pharmaceuticals Industries Ltd. Company Profile and Main Business

10.2.5 Sun Pharmaceuticals Industries Ltd. Recent Developments

10.3 Chiasma Inc

10.3.1 Chiasma Inc Company Information, Head Office, Market Area and Industry Position

10.3.2 Chiasma Inc Medication for Portal Hypertension Models, Specifications and Application

10.3.3 Chiasma Inc Medication for Portal Hypertension Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Chiasma Inc Company Profile and Main Business

10.3.5 Chiasma Inc Recent Developments

10.4 Ono Pharmaceutical Co., Ltd.

10.4.1 Ono Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area and Industry Position

10.4.2 Ono Pharmaceutical Co., Ltd. Medication for Portal Hypertension Models, Specifications and Application

10.4.3 Ono Pharmaceutical Co., Ltd. Medication for Portal Hypertension Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.4.4 Ono Pharmaceutical Co., Ltd. Company Profile and Main Business

10.4.5 Ono Pharmaceutical Co., Ltd. Recent Developments

10.5 Novartis AG

10.5.1 Novartis AG Company Information, Head Office, Market Area and Industry Position

10.5.2 Novartis AG Medication for Portal Hypertension Models, Specifications and Application

10.5.3 Novartis AG Medication for Portal Hypertension Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.5.4 Novartis AG Company Profile and Main Business

10.5.5 Novartis AG Recent Developments

10.6 Dr. Falk Pharma GmbH

10.6.1 Dr. Falk Pharma GmbH Company Information, Head Office, Market Area and Industry Position

10.6.2 Dr. Falk Pharma GmbH Medication for Portal Hypertension Models, Specifications and Application

10.6.3 Dr. Falk Pharma GmbH Medication for Portal Hypertension Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.6.4 Dr. Falk Pharma GmbH Company Profile and Main Business

10.6.5 Dr. Falk Pharma GmbH Recent Developments

10.7 Gilead Sciences Inc.

10.7.1 Gilead Sciences Inc. Company Information, Head Office, Market Area and Industry Position

10.7.2 Gilead Sciences Inc. Medication for Portal Hypertension Models, Specifications and Application

10.7.3 Gilead Sciences Inc. Medication for Portal Hypertension Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.7.4 Gilead Sciences Inc. Company Profile and Main Business

10.7.5 Gilead Sciences Inc. Recent Developments

10.8 United Therapeutics Corporation

10.8.1 United Therapeutics Corporation Company Information, Head Office, Market Area and Industry Position

10.8.2 United Therapeutics Corporation Medication for Portal Hypertension Models, Specifications and Application

10.8.3 United Therapeutics Corporation Medication for Portal Hypertension Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.8.4 United Therapeutics Corporation Company Profile and Main Business

10.8.5 United Therapeutics Corporation Recent Developments

10.9 Debiovision, Inc.

10.9.1 Debiovision, Inc. Company Information, Head Office, Market Area and Industry Position

10.9.2 Debiovision, Inc. Medication for Portal Hypertension Models, Specifications and Application

10.9.3 Debiovision, Inc. Medication for Portal Hypertension Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.9.4 Debiovision, Inc. Company Profile and Main Business

10.9.5 Debiovision, Inc. Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Medication for Portal Hypertension Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Medication for Portal Hypertension Market Restraints

Table 3. Medication for Portal Hypertension Market Trends

Table 4. Medication for Portal Hypertension Industry Policy

Table 5. Global Medication for Portal Hypertension Revenue by Company, 2019-2024, US$ million

Table 6. Global Medication for Portal Hypertension Revenue Market Share by Company, 2019-2024

Table 7. Global Medication for Portal Hypertension Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Medication for Portal Hypertension Sales Volume Market Share by Company, 2019-2024

Table 9. Global Medication for Portal Hypertension Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Medication for Portal Hypertension Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Medication for Portal Hypertension Mergers & Acquisitions, Expansion Plans

Table 12. Global Medication for Portal Hypertension Manufacturers Product Type

Table 13. China Medication for Portal Hypertension Revenue by Company, 2019-2024, US$ million

Table 14. China Medication for Portal Hypertension Revenue Market Share by Company, 2019-2024

Table 15. China Medication for Portal Hypertension Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Medication for Portal Hypertension Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Medication for Portal Hypertension Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Medication for Portal Hypertension Import & Export Trends

Table 19. Main Sources of China Medication for Portal Hypertension Import

Table 20. Export Destination of China Medication for Portal Hypertension

Table 21. Global Headquarters and Manufacturing Base of Medication for Portal Hypertension Manufacturers

Table 22. Global Major Manufacturers, Medication for Portal Hypertension Capacity Expansion and Future Plans

Table 23. Global Medication for Portal Hypertension Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Medication for Portal Hypertension Production by Region, 2019-2024, (K Units)

Table 25. Global Medication for Portal Hypertension Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Medication for Portal Hypertension Upstream (Raw Materials)

Table 27. Global Medication for Portal Hypertension Typical Customers

Table 28. Medication for Portal Hypertension Typical Distributors

Table 29. By Type, Global Medication for Portal Hypertension Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Medication for Portal Hypertension Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Medication for Portal Hypertension Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Medication for Portal Hypertension Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Medication for Portal Hypertension Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Medication for Portal Hypertension Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Medication for Portal Hypertension Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Medication for Portal Hypertension Revenue Market Share, 2019-2030

Table 37. By Country, Global Medication for Portal Hypertension Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Medication for Portal Hypertension Sales Volume Market Share, 2019-2030

Table 39. Genextra S.p.a. Company Information, Head Office, Market Area and Industry Position

Table 40. Genextra S.p.a. Medication for Portal Hypertension Models, Specifications and Application

Table 41. Genextra S.p.a. Medication for Portal Hypertension Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Genextra S.p.a. Company Profile and Main Business

Table 43. Genextra S.p.a. Recent Developments

Table 44. Sun Pharmaceuticals Industries Ltd. Company Information, Head Office, Market Area and Industry Position

Table 45. Sun Pharmaceuticals Industries Ltd. Medication for Portal Hypertension Models, Specifications and Application

Table 46. Sun Pharmaceuticals Industries Ltd. Medication for Portal Hypertension Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Sun Pharmaceuticals Industries Ltd. Company Profile and Main Business

Table 48. Sun Pharmaceuticals Industries Ltd. Recent Developments

Table 49. Chiasma Inc Company Information, Head Office, Market Area and Industry Position

Table 50. Chiasma Inc Medication for Portal Hypertension Models, Specifications and Application

Table 51. Chiasma Inc Medication for Portal Hypertension Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Chiasma Inc Company Profile and Main Business

Table 53. Chiasma Inc Recent Developments

Table 54. Ono Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 55. Ono Pharmaceutical Co., Ltd. Medication for Portal Hypertension Models, Specifications and Application

Table 56. Ono Pharmaceutical Co., Ltd. Medication for Portal Hypertension Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Ono Pharmaceutical Co., Ltd. Company Profile and Main Business

Table 58. Ono Pharmaceutical Co., Ltd. Recent Developments

Table 59. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 60. Novartis AG Medication for Portal Hypertension Models, Specifications and Application

Table 61. Novartis AG Medication for Portal Hypertension Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Novartis AG Company Profile and Main Business

Table 63. Novartis AG Recent Developments

Table 64. Dr. Falk Pharma GmbH Company Information, Head Office, Market Area and Industry Position

Table 65. Dr. Falk Pharma GmbH Medication for Portal Hypertension Models, Specifications and Application

Table 66. Dr. Falk Pharma GmbH Medication for Portal Hypertension Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Dr. Falk Pharma GmbH Company Profile and Main Business

Table 68. Dr. Falk Pharma GmbH Recent Developments

Table 69. Gilead Sciences Inc. Company Information, Head Office, Market Area and Industry Position

Table 70. Gilead Sciences Inc. Medication for Portal Hypertension Models, Specifications and Application

Table 71. Gilead Sciences Inc. Medication for Portal Hypertension Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Gilead Sciences Inc. Company Profile and Main Business

Table 73. Gilead Sciences Inc. Recent Developments

Table 74. United Therapeutics Corporation Company Information, Head Office, Market Area and Industry Position

Table 75. United Therapeutics Corporation Medication for Portal Hypertension Models, Specifications and Application

Table 76. United Therapeutics Corporation Medication for Portal Hypertension Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. United Therapeutics Corporation Company Profile and Main Business

Table 78. United Therapeutics Corporation Recent Developments

Table 79. Debiovision, Inc. Company Information, Head Office, Market Area and Industry Position

Table 80. Debiovision, Inc. Medication for Portal Hypertension Models, Specifications and Application

Table 81. Debiovision, Inc. Medication for Portal Hypertension Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Debiovision, Inc. Company Profile and Main Business

Table 83. Debiovision, Inc. Recent Developments

List of Figure

Figure 1. Medication for Portal Hypertension Picture

Figure 2. By Revenue, Global Medication for Portal Hypertension Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Medication for Portal Hypertension Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Medication for Portal Hypertension Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Medication for Portal Hypertension Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Medication for Portal Hypertension Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Medication for Portal Hypertension Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Medication for Portal Hypertension Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Medication for Portal Hypertension Share of Global Market, 2019-2030

Figure 10. Global Medication for Portal Hypertension Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Medication for Portal Hypertension Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Medication for Portal Hypertension Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Medication for Portal Hypertension Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Medication for Portal Hypertension Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Medication for Portal Hypertension Domestic VS Export, 2022

Figure 16. Global Medication for Portal Hypertension Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Medication for Portal Hypertension Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Medication for Portal Hypertension Production Market Share & Forecast by Region, 2019-2030

Figure 19. Medication for Portal Hypertension Industry Chain

Figure 20. Medication for Portal Hypertension Procurement Model

Figure 21. Medication for Portal Hypertension Sales Model

Figure 22. Medication for Portal Hypertension Sales Channels, Direct Sales and Distribution

Figure 23. Beta-Blockers

Figure 24. Vasodilators

Figure 25. Lactulose

Figure 26. Antibiotics

Figure 27. Diuretics

Figure 28. By Type, Global Medication for Portal Hypertension Revenue, 2019-2030, US$ Million

Figure 29. By Type, Global Medication for Portal Hypertension Revenue Market Share, 2019-2030

Figure 30. By Type, Global Medication for Portal Hypertension Sales Volume, 2019-2030, (K Units)

Figure 31. By Type, Global Medication for Portal Hypertension Sales Volume Market Share, 2019-2030

Figure 32. By Type, Global Medication for Portal Hypertension Price, 2019-2030, (US$/Unit)

Figure 33. Hospital

Figure 34. Specialist Clinic

Figure 35. Others

Figure 36. By Application, Global Medication for Portal Hypertension Revenue, 2019-2030, US$ Million

Figure 37. By Application, Global Medication for Portal Hypertension Revenue Market Share, 2019-2030

Figure 38. By Application, Global Medication for Portal Hypertension Sales Volume, 2019-2030, (K Units)

Figure 39. By Application, Global Medication for Portal Hypertension Sales Volume Market Share, 2019-2030

Figure 40. By Application, Global Medication for Portal Hypertension Price, 2019-2030, (US$/Unit)

Figure 41. By Region, Global Medication for Portal Hypertension Revenue Market Share, 2019-2030

Figure 42. By Region, Global Medication for Portal Hypertension Sales Volume Market Share, 2019-2030

Figure 43. North America Medication for Portal Hypertension Revenue & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, North America Medication for Portal Hypertension Revenue Market Share, 2022

Figure 45. Europe Medication for Portal Hypertension Revenue & Forecasts, 2019-2030, US$ Million

Figure 46. By Country, Europe Medication for Portal Hypertension Revenue Market Share, 2022

Figure 47. Asia Pacific Medication for Portal Hypertension Revenue & Forecasts, 2019-2030, US$ Million

Figure 48. By Country/Region, Asia Pacific Medication for Portal Hypertension Revenue Market Share, 2022

Figure 49. South America Medication for Portal Hypertension Revenue & Forecasts, 2019-2030, US$ Million

Figure 50. By Country, South America Medication for Portal Hypertension Revenue Market Share, 2022

Figure 51. Middle East & Africa Medication for Portal Hypertension Revenue & Forecasts, 2019-2030, US$ Million

Figure 52. U.S. Medication for Portal Hypertension Sales Volume, 2019-2030, (K Units)

Figure 53. By Company, U.S. Medication for Portal Hypertension Market Share, 2022

Figure 54. By Type, U.S. Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 55. By Application, U.S. Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 56. Europe Medication for Portal Hypertension Sales Volume, 2019-2030, (K Units)

Figure 57. By Company, Europe Medication for Portal Hypertension Market Share, 2022

Figure 58. By Type, Europe Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 59. By Application, Europe Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 60. China Medication for Portal Hypertension Sales Volume, 2019-2030, (K Units)

Figure 61. By Company, China Medication for Portal Hypertension Market Share, 2022

Figure 62. By Type, China Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 63. By Application, China Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 64. Japan Medication for Portal Hypertension Sales Volume, 2019-2030, (K Units)

Figure 65. By Company, Japan Medication for Portal Hypertension Market Share, 2022

Figure 66. By Type, Japan Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 67. By Application, Japan Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 68. South Korea Medication for Portal Hypertension Sales Volume, 2019-2030, (K Units)

Figure 69. By Company, South Korea Medication for Portal Hypertension Market Share, 2022

Figure 70. By Type, South Korea Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 71. By Application, South Korea Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 72. Southeast Asia Medication for Portal Hypertension Sales Volume, 2019-2030, (K Units)

Figure 73. By Company, Southeast Asia Medication for Portal Hypertension Market Share, 2022

Figure 74. By Type, Southeast Asia Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 75. By Application, Southeast Asia Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 76. India Medication for Portal Hypertension Sales Volume, 2019-2030, (K Units)

Figure 77. By Company, India Medication for Portal Hypertension Market Share, 2022

Figure 78. By Type, India Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 79. By Application, India Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 80. Middle East & Asia Medication for Portal Hypertension Sales Volume, 2019-2030, (K Units)

Figure 81. By Company, Middle East & Asia Medication for Portal Hypertension Market Share, 2022

Figure 82. By Type, Middle East & Asia Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 83. By Application, Middle East & Asia Medication for Portal Hypertension Sales Volume Market Share, 2022 VS 2029

Figure 84. Research Methodology

Figure 85. Breakdown of Primary Interviews

Figure 86. Bottom-up Approaches

Figure 87. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)